Utah Medical Products, Inc. reported first‑quarter 2026 results that showed a 10.2% decline in revenue to $8.7 million compared with $9.7 million in Q1 2025, reflecting the loss of sales to a former China distributor and PendoTECH. The company’s net income fell 14.4% to $2.6 million, and earnings per share dropped 11% to $0.818 from $0.919 in the prior year, underscoring the impact of the customer losses on profitability.
Gross profit margin expanded to 60.6% in Q1 2026 from 57.0% in Q1 2025, driven by cost‑control measures and a higher mix of high‑margin products. However, operating income margin contracted to 29.4% from 32.5% year‑over‑year because general and administrative expenses rose, offsetting the margin benefit from the higher gross profit. The company’s cash and investments increased to $87.4 million, reinforcing its strong liquidity position and ability to fund ongoing operations and shareholder returns.
Management noted that the quarter’s performance was in line with its previously announced 2026 full‑year guidance, which had been set before the loss of the key customers. The company emphasized that it is actively working to replace the lost revenue streams and expects gross margins to improve further as lower‑margin China sales phase out. Management also highlighted the ongoing Filshie Clip litigation, which, while a potential risk, has not yet materially affected the company’s financials.
The results illustrate a deceleration in top‑line growth but also demonstrate resilience in cost management and cash generation. Investors will likely focus on the company’s ability to recover lost customer volume, maintain margin expansion, and navigate the legal exposure surrounding the Filshie Clip System as it moves forward into 2026.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.